Synthesis of deuterium labelled analogs of fluazifop and haloxyfop
✍ Scribed by Michael J. Bartels; Sterling C. Gatling
- Publisher
- John Wiley and Sons
- Year
- 1990
- Tongue
- French
- Weight
- 228 KB
- Volume
- 28
- Category
- Article
- ISSN
- 0022-2135
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Synthetic routes have been described for the preparation of stable isotope‐labelled analogs of two aryloxyphenoxypropionates, each containing approximately four deuterium atoms in the central phenyl ring of the molecule. Fluazifop‐2′,3′,5′,6′‐^2^H~4~ [2‐(4‐((5‐(trifluoromethyl)‐2‐pyridinyl)‐oxy)phenoxy)propionic acid‐2′,3′,5′,6′‐^2^H~4~] and haloxyfop‐2′,3′,5′,6′‐^2^H~4~ [2‐(4‐((3‐chloro‐5‐(trifluoromethyl)‐2‐pyridinyl)oxy)phenoxy)propionic acid‐2′,3′,5′,6′‐^2^H~4~] were synthesized from the common intermediate HPPA‐2′,3′,5′,6′‐^2^H~4~ [2‐(4‐hydroxyphenoxy)propionic acid‐2′,3′,5′,6′‐^2^H~4~]. This intermediate was obtained from HPPA via acid‐catalyzed deuterium exchange (^2^H~2~SO~4~ in ^2^H~2~O and CH~3~O^2^H).
📜 SIMILAR VOLUMES
## Abstract Procedures for the preparation of trifluoperazine with two, four and six deuterium atoms are described. Deuterium was introduced in the propylpiperazine side chain by treatment of the appropriate amide with lithium aluminium deuteride. The isotopic purity of the products was greater tha
## Abstract Trantinterol, a selective β~2~‐adrenoceptor agonist, is currently in Phase II clinical trials for the treatment of asthma and bronchitis. The synthesis of deuterium‐labelled trantinterol is described. The labelled trantinterol is used as an internal standard for the analysis and metabol
## Abstract This study describes the synthesis of deuterium‐labelled etravirine. Etravirine labelled with six deuteriums was prepared in eight steps starting from phenol with excellent chemical purity and isotopic enrichment. It provides important internal standard for the clinical studies of etrav